IndiaIntravenous Anesthetic Market, by Type (Barbiturates, Ketamine,Benzodiazepines, Propofol, and Others) and by End User (Hospitals, Clinics, andOthers) is estimated to be valued at US$ 65.0 million in 2019 and is expectedto exhibit a CAGR of 2.6% over the forecast period (2019-2027), as highlightedin a new report published by Coherent Market Insights.
Intravenous anesthetics are agroup of fast-acting compounds that are used to induce complete sedation. Someof the important intravenous anesthetics include propofol, etomidate, ketamine,and barbiturates. The increasing number of surgeries in India is a key factorthat is expected to drive growth of the India intravenous anesthetic marketover the forecast period. Moreover, increasing number of heart disease in Indiais one of the key factor that leads to rising number of different surgeries inIndia. For instance, according to the CADI Research Foundation data, in 2010,around 47 million Indians suffered from coronary artery disease (CAD). Moreover,around 60,000 coronary bypass surgeries are performed every year in India. Suchhigh number of surgeries performed in India is expected to fuel growth of theIndia intravenous anesthetic market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3558
Increasing adoption of surgicalrobots made advancement in surgical procedures which is expected to fuel growthof the India intravenous anesthetic market over the forecast period.Advancements in surgical products and technologies have led to shift fromconventional surgeries to minimally invasive surgeries. The usage of robotictechnology conducting minimally invasive surgeries has resulted in significantchanges in surgical procedures. The acceptance of robotic surgeries increasedthe number of surgeries performed in India. Moreover, these increasing surgeriesare expected to drive growth of the India intravenous anesthetic market overthe forecast period.
Browse 13 Market Data Tables and11 figures spread through 82 pages and in-depth TOC on 'India intravenousanesthetic market, Forecast to 2027'
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/india-intravenous-anesthetic-market-3558
Key Takeaways of the Indiaintravenous anesthetic market:
India intravenous anestheticmarket is expected to exhibit a CAGR of 2.6% over the forecast period(2019-2027), owing to increasing number of surgeries performed in India
Among type, propofol segment isexpected to hold a dominant position in the India intravenous anestheticmarket, owing to high adoption of propofol by Indian healthcare professionalfor anesthetic procedure
Major players operating in theIndia intravenous anesthetic market include AstraZeneca Plc, Fresenius Kabi,AbbVie Inc., Baxter International Inc., B. Braun Melsungen AG, MaruishiPharmaceutical Co., Ltd, Piramal Healthcare, Hikma Pharmaceuticals, and MylanN.V.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3558
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
